Transparency data

Voluntary scheme aggregate net sales and payment information: February 2025

Information on how the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is controlling spend on branded medicines in the NHS.

From:
Department of Health and Social Care
Published
21 March 2025

Documents

Aggregate net sales and payment information: February 2025

HTML

Details

This document sets out the聽NHS鈥檚 quarterly aggregate net sales and payment information on pharmaceuticals for February 2025.

罢丑别听2024 voluntary scheme for branded medicines pricing, access and growth听(VPAG)聽is an agreement between the Department for Health and Social Care,聽NHS聽England and the Association of the British Pharmaceutical Industry that aims to:

  • promote better patient outcomes and a healthier population
  • support UK economic growth
  • contribute to a financially sustainable NHS

Updates to this page

Published 21 March 2025

Sign up for emails or print this page

Related content